OvaScience is a global fertility company dedicated to improving treatment options for women around the world. OvaScience is discovering, developing and commercializing new fertility treatments. Each OvaScience treatment is based on the Company’s proprietary technology platform that leverages the breakthrough discovery of egg precursor (EggPCSM) cells – immature egg cells found inside the protective ovarian lining. The AUGMENTSM treatment, a fertility option specifically designed to improve egg health, is available in certain IVF clinics in select international regions outside of the United States. OvaScience has commenced a non-commercial preceptorship program with OvaPrimeSM treatment, which could increase a woman’s egg reserve, and is developing the OvaTureSM treatment, a potential next-generation IVF treatment that could help a woman produce healthy, young, fertilizable eggs without hormone injections.

TypePublic
HQWaltham, US
Founded2011
Size (employees)118 (est)
Websiteovascience.com
OvaScience was founded in 2011 and is headquartered in Waltham, US
Report incorrect company information

Viewing summary data as a guest

Sign up for free to see all data

Key People/Management at OvaScience

David Sinclair

David Sinclair

Co-Founder & Scientific Advisor
Show more

OvaScience Office Locations

OvaScience has an office in Waltham
Waltham, US (HQ)
9 4th Ave
Show all (1)
Report incorrect company information

OvaScience Financials and Metrics

OvaScience Revenue

OvaScience's revenue was reported to be $653 k in FY, 2016
USD

Revenue (Q2, 2018)

148.0k

Gross profit (Q2, 2018)

(18.0k)

Gross profit margin (Q2, 2018), %

(12.2%)

Net income (Q2, 2018)

(15.1m)

EBIT (Q2, 2018)

(15.5m)

Market capitalization (15-Oct-2018)

26.8m

Closing stock price (15-Oct-2018)

0.8

Cash (30-Jun-2018)

24.6m
OvaScience's current market capitalization is $26.8 m.
Annual
USDFY, 2016

Revenue

653.0k

General and administrative expense

49.2m

R&D expense

21.6m

Operating expense total

70.9m
Quarterly
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q1, 2018Q2, 2018

Revenue

15.0k30.0k75.0k146.0k189.0k197.0k63.0k67.0k148.0k

Cost of goods sold

112.0k166.0k

Gross profit

(45.0k)(18.0k)

Gross profit Margin, %

(67%)(12%)
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

18.1m6.4m43.2m43.9m

Inventories

650.0k1.6m3.0m2.1m

Current Assets

45.1m61.9m129.9m116.4m
Quarterly
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q1, 2018Q2, 2018

Cash

16.6m12.1m134.7m70.2m50.8m20.5m95.9m50.5m25.4m19.7m24.6m

Current Assets

82.6m73.6m171.3m159.2m145.3m112.7m150.1m133.5m101.2m59.1m54.2m

PP&E

1.9m3.1m4.2m4.2m6.7m8.7m8.1m8.0m4.7m2.9m403.0k

Total Assets

85.8m77.5m175.8m164.5m152.8m122.1m158.7m142.4m106.3m63.0m55.5m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(2.6m)(49.5m)(73.2m)(82.3m)

Depreciation and Amortization

450.0k1.3m2.2m

Accounts Payable

276.0k2.3m(171.0k)(1.2m)
Quarterly
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q1, 2018Q2, 2018

Net Income

(9.9m)(12.9m)(17.2m)(17.5m)(17.9m)(21.8m)(18.6m)(19.3m)(14.9m)(7.4m)(15.1m)

Depreciation and Amortization

330.0k506.0k

Accounts Payable

1.4m3.0m2.5m3.0m4.2m4.2m2.5m2.8m2.4m(1.4m)(1.5m)

Cash From Operating Activities

(8.9m)(13.8m)
USDY, 2018

Financial Leverage

1.1 x
Show all financial metrics
Report incorrect company information

OvaScience Online and Social Media Presence

Embed Graph
Report incorrect company information

OvaScience Company Life and Culture

Report incorrect company information